Created with Highcharts 10.1.0Chart context menu


Selling And Administration Expenses 更改
AstraZeneca USD 5.55B 307M 2024-12
Autolus Therapeutics Ltd 33.68M 6.35M 2024-12
Hikma Pharmaceutical USD 280M 4M 2024-06
Novartis USD 3.5B 368M 2024-12
Roche Holding CHF 3.61B 381M 2024-12
Silence Therapeutics 5.6M 312K 2024-09



Autolus Therapeutics Ltd 销售和管理费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2025.